2022
Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19
Wells CR, Pandey A, Gokcebel S, Krieger G, Donoghue AM, Singer BH, Moghadas SM, Galvani AP, Townsend JP. Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19. PNAS Nexus 2022, 1: pgac100. PMID: 35909795, PMCID: PMC9335027, DOI: 10.1093/pnasnexus/pgac100.Peer-Reviewed Original ResearchSARS-CoV-2Serial testingSerial testing strategyHigh population immunityQuarantine durationBenefits of vaccinationSARS-CoV-2 variantsDisease time courseCOVID-19CoV-2 variantsPublic health toolVaccine boostingThird doseVaccination statusVaccination coveragePopulation immunityCoV-2Health toolsDisease control effortsInfected casesLocal transmissionInfectiousness profileVaccinationTime courseImmunity
2020
Prosocial polio vaccination in Israel
Wells CR, Huppert A, Fitzpatrick MC, Pandey A, Velan B, Singer BH, Bauch CT, Galvani AP. Prosocial polio vaccination in Israel. Proceedings Of The National Academy Of Sciences Of The United States Of America 2020, 117: 13138-13144. PMID: 32457142, PMCID: PMC7293608, DOI: 10.1073/pnas.1922746117.Peer-Reviewed Original ResearchConceptsOral polio vaccineOPV campaignsPolio vaccineVaccination behaviorInactivated polio vaccineGreater vaccination coverageRisk of paralysisProsocial vaccinationVaccination coverageVaccine campaignPolio vaccinationVaccinationInsufficient vaccinationPoliomyelitis eradicationSurveillance programVaccineSporadic outbreaksIsrael MinistryPrimary objectiveProsocial natureParalysisDiseasePolio